Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

Press releases published on May 1, 2026

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Acorn, Provider of Monitoring and Control Solutions for Generators, Cell Towers, Data Centers and other Critical Infrastructure, Hosts Q1 Earnings Call Thursday, May 7 at 11am ET
Tstrive Review: A New Balanced Look at the Men’s Vitality and Energy Supplement
Water splitting catalyst creates hydrogen at low temperatures
GuardHouse Camera Analyzed: All You Need To Know About the GuardHouse Watch Eye
Generative Artificial Intelligence (AI) in Material Science Market: Trends & Segment Forecasts to 2030
Eros Wellness Launches India’s First Sovereign AI-Powered Preventive Primary Healthcare Clinic in Gandhinagar
Whitespace Makes Iris, AI Intelligence Analysis Agent, Generally Available to Authorized DoW and IC Users
What Happens After the Breakthrough: At KFSH, Innovation Is Measured by Repetition
Results of Annual General Meeting
Roadzen to Attend Nordics’ Leading Automotive Event VECS 2026 in Gothenburg on May 5–6
StellarSpace Unveils New-Generation Industrial Automation Products at Silicon Valley Launch Event
General Catalyst Global Resilience Merger Corp. Announces Closing of $402.5 Million Initial Public Offering
Human Garage launches Global 28-Day Reset on May 1 to help millions release stress and pain
Free AI Crypto Trading App by AriseAlpha: Smart Automated Trading in 2026
Bitdeer Announces First Quarter 2026 Earnings Conference Call for May 14th 2026
Arvinas Announces FDA Approval of VEPPANU (vepdegestrant) for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer

Share this page:

Sign up for:

Science Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.